ATLANTA, ga – May 01, 2024
SENTA Continues Strategic Growth Partnering with CornerStone Ear, Nose & Throat, Expanding Footprint in North Carolina
SENTA Partners has further broadened its footprint in the Southern US, reaching nearly 190 providers and 74 locations.
SENTA (“Southern Ear, Nose, Throat and Allergy Physicians”) proudly announces its partnership with CornerStone Ear, Nose & Throat, a move that expands its footprint in North Carolina, specifically in the Charlotte metropolitan area. This partnership underscores SENTA’s significant strategic growth envisioned for 2024.
CornerStone Ear, Nose & Throat, a trusted specialty healthcare provider for 30 years, has served the Charlotte community with a team of board-certified otolaryngologists and medical/audiology professionals dedicated to improving the lives of adults and children. With this partnership, CornerStone Ear, Nose & Throat joins SENTA’s physician-led, patient-focused alliance, aligning their commitment to clinical expertise and personalized patient care.
“I’m thrilled to partner with the great team at SENTA Partners. This partnership allows us to join a network of strong physicians in the Charlotte area and throughout the South,” said William McClelland, MD, FACS, Founding and Owner Physician of CornerStone Ear, Nose & Throat. “Our primary focus has always been on positively impacting the lives of our patients by providing excellent communication with our patients and referring physicians and clinical excellence. We look forward to leveraging SENTA’s business expertise and resources to enhance our services and better serve our patients and community.”
“We are excited to welcome Dr. William McClelland and the CornerStone Ear, Nose & Throat team to the SENTA Partners family of ENT and Allergy Practices,” said Adam Low, CEO of SENTA. “Their 30-year history of providing exceptional ENT care perfectly aligns with SENTA's mission of delivering the highest level of specialty care to patients across the South."
With the addition of CornerStone Ear, Nose & Throat, SENTA now boasts 1,050 employees, including nearly 190 providers across 74 locations in seven states. For those interested in learning more about ENT and Allergy partnerships with SENTA, please contact the Chief Development Officer, Zack Usilton, at Zack.Usilton@SENTAPartners.com.
Figure 1: Stephanie Griffin, AuD, Daniel Gerry, MD, Gabrielle Crawford, AuD, Natalie Macknet, FNP-C, Mary Darko, AuD, Matthew Gillihan, MD, William McClelland, MD, FACS, Karen Green, PA-C
Figure 2: 8035 Providence Rd., #320, Phone: 704-752-7575
ABOUT SENTA PARTNERS
Southern Ear, Nose, Throat and Allergy Physicians (SENTA) is a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region. SENTA provides the highest quality allergy, asthma, immunology, and otolaryngology care, leading to better patient outcomes. Founded in 2019 with an investment from Shore Capital Partners, SENTA provides strategic, operational, and administrative support to our ENT and Allergy partner practices, empowering physicians to focus on their patients. In 2023, SENTA was named #588 on the INC. 5000 list of fastest-growing private companies in America. For additional information on SENTA, please visit www.sentapartners.com.
ABOUT SHORE CAPITAL PARTNERS
Shore Capital, a Chicago-based private equity firm with offices in Nashville, is an investor in microcap companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore’s strategy is to support management partners to grow faster with less risk, through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020-2023 Shore received recognition from Inc Magazine as a 4x Top Founder Friendly Investor and by Pitchbook Research for being the global leader in Private Equity total deal volume. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has over $6 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. For more information, please visit www.shorecp.com.